Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04922216 · ClinicalTrials.gov registry record · NA
Adaptive Goals and Interventions for Lifestyle Enhancement
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 759
- Enrollment target
NCT04922216: Completed NA study, sponsored by University of North Carolina, Chapel Hill.
NCT04922216 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 759 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (46% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04922216, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 759 participants
- Enrollment target
Study Summary
Mobile obesity interventions have the potential to reach a diverse population in need; however, while effective, have not resulted in weight losses obtained in in-person interventions. Newer digital approaches called Just-in-Time Adaptive Interventions (JITAI) that offer adaptive, personalized feedback 'when needed' and in 'real time' offer an opportunity to use digital health tools "just in time". This study seeks to identify the optimal components of a comprehensive weight loss JITAI that results in weight losses that meet or exceed those in existing remotely delivered interventions.
Primary Outcome
Estimated mean weight change in kg from baseline to 6 months for each of the two levels of each component (factor) obtained from intent-to-treat (ITT) linear mixed models of analysis of variance. More negative values of weight change indicate greater weight loss (6-month weight - baseline weight).
Interventions
- BEHAVIORAL Core
- BEHAVIORAL Standard Diet Monitoring
- BEHAVIORAL Simplified Diet Monitoring
- BEHAVIORAL Adaptive Activity Goals (Daily)
- BEHAVIORAL Adaptive Activity Goals (Weekly)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 759 participants |
| Start Date | 2022-04-28 |
| Est. Completion | 2024-07-01 |
| Phase | NA |
What the finished NCT04922216 record still lists
NCT04922216 is an interventional study that assigns participants to a tested intervention. The registered 759 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (46% lower).
The record links to 0 conditions, and to 5 interventions - of which Core is the first listed.
NCT04922216 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04922216 about?
NCT04922216 is a clinical study titled "Adaptive Goals and Interventions for Lifestyle Enhancement". Mobile obesity interventions have the potential to reach a diverse population in need; however, while effective, have not resulted in weight losses obtained in in-person interventions. Newer digital approaches called Just-in-Time Adaptive Interventions (JITAI) that offer adaptive, personalized feedb...
What is the current status of trial NCT04922216?
This trial is currently completed. It is a NA study. The enrollment target is 759 participants. The study started on 2022-04-28. Estimated completion is 2024-07-01.
What interventions are being tested in trial NCT04922216?
The interventions under investigation include: Core (BEHAVIORAL), Standard Diet Monitoring (BEHAVIORAL), Simplified Diet Monitoring (BEHAVIORAL), Adaptive Activity Goals (Daily) (BEHAVIORAL), Adaptive Activity Goals (Weekly) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04922216?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04922216's enrollment target sits among peer trials
759 145th of 2000 higher than 1,856 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02089607 · 760 participants · NA
CAAAs, TAAAs, Aortic Arch Aneurysms or Dissections With Fenestrated/Branched Stent Graft
- NCT04073706 · 760 participants · Phase 3
Sentinel Node Biopsy in Endometrial Cancer
- NCT05129228 · 760 participants · NA
Optical Coherence Tomography of the Saphenous Vein Graft
- NCT05787821 · 760 participants
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI